comparemela.com

Latest Breaking News On - Eton pharmaceuticals - Page 27 : comparemela.com

Five things for pharma marketers to know: Thursday, March 16, 2023

Mediar Therapeutics raises $85 million to develop drugs for diseases that cause scarring in organs; Bellicum Pharmaceuticals halted its Phase I/II trials after a serious adverse event; The Food and Drug Administration says Paxlovid is not associated with COVID rebound.

Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600

Eton Pharmaceuticals Inc (ETON) acquires rare disease product candidate ET-600 from Tulex

Eton Pharmaceuticals Inc (ETON) acquires rare disease product candidate ET-600 from Tulex
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Eton Pharmaceuticals buys experimental drug

Deer Park-based Eton Pharmaceuticals said Wednesday it has acquired a hormone treatment candidate called ET-600 from Tulex Pharmaceuticals.

Eton Pharmaceuticals Inc (ETON) Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection

Eton Pharmaceuticals Inc (ETON) Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.